Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962779 · ClinicalTrials.gov registry record · NA
Sleep, Aging and Risk for Alzheimer's Disease
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT01962779 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 235 participants.
The verdict
NCT01962779, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
Our preliminary data show for in cognitively-normal elderly, that Sleep Disordered Breathing (SDB) is associated with the increase of cerebrospinal fluid (CSF) phosphorylated-Tau (P-Tau) and total-Tau (T-Tau), decreases in medial temporal lobe glucose uptake (FDG-PET) and volume (MRI) and progressive memory decline, all of which have been shown to be useful in predicting future dementia in older adults. These findings raise the question as to whether Alzheimer's disease (AD) tissue damage causes SDB in the elderly, or alternatively, if SDB acts as a risk factor for AD neurodegeneration. In the proposed study, we will investigate these mechanistic hypotheses in cognitively normal elderly by examining the longitudinal associations between SDB and cognitive decline, novel MR neuroimaging and CSF biomarkers for neurodegeneration; while our secondary goal is to launch a pilot treatment study to aid in interpreting the mechanistic hypotheses and to examine the effects of nasal continuous positive airway pressure (CPAP) on cognitive decline and neurodegeneration.
Interventions
- OTHER Continuous positive airway pressure (CPAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2013-07-31 |
| Est. Completion | 2017-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01962779
The ClinicalTrials.gov registry entry for NCT01962779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous positive airway pressure (CPAP) is the first listed.
NCT01962779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01962779 about?
NCT01962779 is a clinical study titled "Sleep, Aging and Risk for Alzheimer's Disease". Our preliminary data show for in cognitively-normal elderly, that Sleep Disordered Breathing (SDB) is associated with the increase of cerebrospinal fluid (CSF) phosphorylated-Tau (P-Tau) and total-Tau (T-Tau), decreases in medial temporal lobe glucose uptake (FDG-PET) and volume (MRI) and progressiv...
What is the current status of trial NCT01962779?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2013-07-31. Estimated completion is 2017-05-03.
What interventions are being tested in trial NCT01962779?
The interventions under investigation include: Continuous positive airway pressure (CPAP) (OTHER).
Who is sponsoring clinical trial NCT01962779?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.